Navigation Links
TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Date:8/27/2007

ally from the above forward-looking statements due to a number of other important factors. These and other risks which may impact management's expectations are described in greater detail in the TorreyPines Therapeutics' annual report on Form 10-K for the year ended December 31, 2006 as well as TorreyPines Therapeutics' subsequent filings with the Securities and Exchange Commission. TorreyPines Therapeutics undertakes no obligation to publicly release the result of any revisions to such forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will ... on Wednesday, May 6, 2015, following the close of the ... conference call and live webcast on the same day at ... discuss the financial results.  To access the ... the "Investors" link.  Please log onto the webcast prior to ...
(Date:4/16/2015)... Kenneth C. Frazier , chairman and chief executive officer ... the Board of the Pharmaceutical Research and Manufacturers of America ... John J. Castellani announced that he will be retiring ... to PhRMA Board Frazier formerly held the position ... and CEO of Pfizer, Inc. Also elected were George ...
(Date:4/16/2015)... YORK , April 16, 2015 An ... additional way to generate trimers from the major HIV ... could benefit future clinical development of HIV vaccine candidates ... the critical target on the surface of HIV for ... an important platform for AIDS vaccine discovery, says ...
Breaking Medicine Technology:Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5New Method Holds Promise for HIV Vaccine Development 2
... Corporation (Nasdaq: GNBT, www.generex.com ), the leader in ... of the mouth, today announced that it has been ... Canadian Intellectual Property Office granted Canadian Patent No. 2,401,942, ... Application". This new patent increases the number ...
... International Corporation (Nasdaq: PRXL ) announced today it ... Conference in New York.  James Winschel, Senior Vice President and ... at 11:45 a.m. ET on Tuesday, October 5, 2010. ... through the "Investors" section of PAREXEL,s website at ...
Cached Medicine Technology:Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 2Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 3PAREXEL International to Present at William Blair Emerging Growth Stock Conference 2
(Date:4/19/2015)... The American Institute for Cancer Research (AICR) ... to host its second annual, nationwide Shred Cancer event. ... in order to raise funds for cancer research and ... event is being held at 20+ PROSHRED locations throughout ... time will vary at select locations. , Individuals are ...
(Date:4/19/2015)... WI (PRWEB) April 19, 2015 HealthPostures, ... announces that it will exhibit it’s pioneering ergonomics ... Expo and the Iowa-Illinois Safety Council Professional Development Conference ... and the TaskMate EZ are used in volume by ... facilities. , Built to clamp to a desk, ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog ... cheaper during Spring. , Spring can be a ... should make sure they compare the newest policies before ... learn more about Spring car insurance offers by reading ... quotes are becoming more and more popular. Many insurance ...
(Date:4/18/2015)... has released a new blog post explaining how to ... Clients can review important auto insurance quotes online, by ... advantages for clients who need affordable financial security for ... coverage for their vehicles can purchase a policy at ... agencies offer important discounts and drivers can learn more ...
(Date:4/18/2015)... the past few weeks, TheBeautyPlace.com has been undergoing maintenance ... run maintenance on our shipping facilities to update software ... Director. "It disrupted our regular shipping schedule but we ... track after having completed the maintenance." , Now, TheBeautyPlace.com ... has not allowed some calls to come in through ...
Breaking Medicine News(10 mins):Health News:2015 Annual Nationwide "Shred Cancer" Shredding Event 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2
... poor, has banned the life-threatening practice of female circumcision, the ... in female genital mutilation (FGM) would be punished with a ... follows a campaign against the practice by the National Union ... women are circumcised. ,'Female circumcision is a ...
... of a Canadian university have voted overwhelmingly to remove ... company has implemented// unethical practices in India and Colombia. ... University of Guelph voted last week to remove Coca-Cola ... to India Resource Center, an international campaigning organization that ...
... the developing world? Look at Galway, the third largest city in ... Scores of people have taken ill and tens of thousands are ... ,Water supply in Galway has been hit by an outbreak of ... to have been hit by a serious stomach bug as a ...
... company, Crucell N V’s Rabies monoclonal antibody (mAb) product ... four months after launching// a similar study in the ... monoclonal antibody product for the post-exposure prophylaxis of rabies, ... phase I study is closely linked to the initial ...
... of low-sugar potato, as there is an increasing demand across ... trend is particularly evident in Gujarat in western India, where ... to the new variety. ,The low-sugar potato is ... processing firms snap up the produce without any delay, farmers ...
... major, Intercell and its partner Hyderabad-based Biological E. ... to start// a pediatric phase II clinical trial ... ,The randomized and controlled study aims ... Intercell’s JE vaccine compared to a locally produced ...
Cached Medicine News:Health News:Eritrea Bans Female Circumcision 2Health News:Water Crisis Wreaks Havoc on Irish City 2Health News:Crucell's Rabies MAb Enters Phase I Trial in India 2
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... The Vivid 3 system is designed ... of cardiovascular performance, and offer an even ... pediatrics and the OR. From color flow ... connectivity, the new Vivid 3 offers a ...
... 4 system is an easy-to-use, high-performance ultrasound ... your clinical practice. In effect, GE has ... a value-based combination of proven technology and ... paid heed to features praised by Vivid ...
... remote monitoring from Medtronic is changing the ... care. Using their Medtronic CareLink Monitor and ... send device information from their home or ... site, clinicians have the ability to review ...
Medicine Products: